Oxygen and Pressure Epigenetics: Understanding Hyperbaric Oxygen Therapy After 355 Years as the Oldest Gene Therapy Known to Man
Published in the Townsend Letter April 2018
by Paul G. Harch, MD
Despite the “Decade of the Brain” from 1990-20001 and all the advances of modern medicine, treatment of the most common neurological diseases (traumatic brain injury, stroke, and dementia) has made minimal progress in the last 100 years. In 2017 Alzheimer’s Dementia alone accounts for 5.4 million cases in the U.S. Total costs for dementia are estimated to be $259 million this year. The numbers will burgeon in the decades ahead as the Baby Boomers’ demographic and the excesses of their earlier years pay a negative dividend.
Imagine for a moment a treatment that generically addresses/treats the underlying pathophysiology of traumatic brain injury (TBI), concussion, stroke, dementia, and many other neurological and systemic diseases, a treatment that not only restores reserve capacity, but stimulates repair and regrowth of tissue, a treatment that gives people back their lives.
See the Full preview CLICK HERE: http://townsendletter.wa.newsmemory.com/publink.php?shareid=0060f2ffa
The Townsend Letter, commonly known as the Examiner of Alternative Medicine, has been presenting scientific information since 1983 on a wide variety of medical therapies including Hyperbaric Oxygen Therapy.
